Strategic partnership St. Louis CyberKnife operates as a joint venture involving SSM Cancer Care and local physicians, indicating a collaborative expansion model that may welcome scalable partnerships, new referral networks, and co-branded treatment programs.

Advanced treatment Focus on robotic radiosurgery with sub-millimeter accuracy offers a compelling selling point for referrals seeking non-invasive, precise tumor treatments, particularly for prostate, head, neck, and body tumors.

Tech stack leverage Existing digital infrastructure (iCIMS, WordPress, Google Workspace, Microsoft 365) suggests potential for streamlined outreach, candidate sourcing, and customer engagement initiatives to grow patient referrals and partnerships.

Growth potential Recent public activity includes patient-focused events and awareness around prostate cancer treatment, signaling opportunities to upsell education programs, second opinions, or allied services to expanding patient cohorts.

Market positioning Operating within the healthcare sector in collaboration with a major medical network places the company in a favorable position relative to larger competitors, enabling targeted outreach to hospitals and clinics seeking specialty radiology services.